Related Experiment Video
Updated: Jul 4, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed
Benjamin E Rabichow1,2,3, Lacey Nixon2, Lauren E Tallant2,3
1Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Phoenix, Arizona, USA.
Introduction:
Neurodegenerative diseases often involve overlapping alpha-synuclein (asyn), amyloid beta, and tau proteinopathies, yet the mechanisms, impact, and directionality of their interactions remain unclear.
Methods:
We induced brain-wide neuronal asyn/tau pathologies via viral expression of wild-type asyn, mutant asynE46K, mutant tauA152T, or both asynE46K/tauA152T in adult amyloidosis knock-in mice and controls, either post-plaque deposition (6 months old) or pre-plaque (3 months old). Open-field behavior was assessed baseline and 3 and 6 months post-transduction, followed by neuropathology and neuroinflammation analyses.
Results:
Post-plaque induction in amyloid mice increased asyn/tau total and phosphorylated levels and exacerbated amyloid-related hyperlocomotion/anxiety. Pre-plaque induction produced robust phosphorylated pathologies irrespective of amyloid, while causing similar amyloid-dependent behavioral synergy. Tau pathology drove LGALS3+ inflammatory glial responses in white-matter fibers.
Discussion:
Amyloid context gates vulnerability, with certain synergies manifesting across stages. White-matter gliosis is a novel mechanism of tauA152T risk. Together, our data argue for the development of stage-aware, multitarget interventions and biomarkers.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Parkinson Disease ll: Pathophysiology
Dementia l: Introduction
